-
公开(公告)号：EP3897732A1
公开(公告)日：2021-10-27
申请号：EP19899721.5
申请日：2019-12-13
Applicant: Joyn Botanicals Ltd.
Inventor： ARTISS, Joseph D.
IPC: A61K47/40 , A21D13/00 , A23G3/42 , A23G3/48 , A23L33/10 , A23L33/105 , A23L33/125 , A61K31/05 , A61K31/352 , A61K36/185 , C07C39/23 , C07D311/60 , C07D311/80
-
公开(公告)号：EP3890859A2
公开(公告)日：2021-10-13
申请号：EP19828005.9
申请日：2019-12-02
Applicant: Orochem Technologies, Inc.
Inventor： OROSKAR, Anil , GULATI, Kunal , HOUSE, David , OROSKAR, Asha , OROSKAR, Gautham
IPC: B01D15/18 , B01D15/26 , A61K31/352 , C07D311/80
-
23.发明公开
公开(公告)号：EP3884936A1
公开(公告)日：2021-09-29
申请号：EP21171866.3
申请日：2019-02-11
Applicant: MyMD Pharmaceuticals (Florida), Inc.
Inventor： WILLIAMS, Jonnie R
IPC: A61K31/352 , C07D311/04 , C07D311/80 , C12N15/09
Abstract: A method of increasing the cannabinoid levels in a genetically modified Cannabis sativa plant includes genetically modifying the plant to induce the overexpression of the gene that controls the expression of tetrahydrocannabinolic acid (THCA) synthase and/or cannabidiolic acid (CBDA) synthase. The overexpression of THCA synthase and CBDA synthase catalyzes an increased synthesis of cannabigerolic acid to tetrahydrocannabinolic acid and cannabidiolic acid, as well as the cannabinoids (3aR)-2,4,4-trimethyl-7-pentyl-3,3a,4,9b-tetrahydrocyclopenta[c]chromen-9-ol and 2-((1R,5R)-3-methyl-5-(prop-1-en-2-yl)cyclopent-2-en-1-yl)-5-pentylbenzene-1,3-diol. Pharmaceutical compositions comprising the modified cannabinoids produced by the transgenic Cannabis sativa plant or prepared synthetically are used to treat various diseases and conditions.
-
公开(公告)号：EP3880184A1
公开(公告)日：2021-09-22
申请号：EP19884098.5
申请日：2019-11-13
Applicant: Hexo Operations Inc.
Inventor： ALSAYAR, Max , WOODS, Patrick
IPC: A61K9/72 , A24D1/18 , A61K31/05 , A61K31/352 , A61K47/44 , B05B1/24 , C07C39/23 , C07D311/80 , A61M15/06
-
25.发明公开
公开(公告)号：EP3877374A1
公开(公告)日：2021-09-15
申请号：EP20822282.8
申请日：2020-06-12
Applicant: Nectar Health Sciences Inc.
Inventor： DURST, Tony , VAN DER VLUGT, Jay , SAIKALEY, Amanda
IPC: C07D311/80 , A61K36/185 , C07C211/10 , C07C211/63 , C07D211/06 , C07D453/02
-
Patent Agency Ranking
公开(公告)号：EP3866962A1
公开(公告)日：2021-08-25
申请号：EP19873938.5
申请日：2019-10-16
Applicant: Silicycle Inc.
-
公开(公告)号：EP3722277A3
公开(公告)日：2021-01-20
申请号：EP20160770.2
申请日：2014-10-01
Applicant: Novartis AG
Inventor： BARYZA, Jeremy Lee , BLOMMERS, Marcel , FERNANDEZ, Cesar , GENO, Erin , GOSSERT, Alvar , GREENIDGE, Paulette , HUESKEN, Dieter , HUNZIKER, Juerg , NATT, Francois Jean-Charles , PATNAIK, Anup , PATTERSON, Andrew , RONDEAU, Jean-Michel Rene , WEILER, Jan , ZHU, Meicheng
IPC: C07C43/178 , C07C69/40 , C07D213/30 , C07D215/12 , C07D215/14 , C07D217/14 , C07D311/80 , C07D401/04 , C12N15/11
Abstract: The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3' end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.
-
公开(公告)号：EP3703839A1
公开(公告)日：2020-09-09
申请号：EP18876158.9
申请日：2018-11-08
Applicant: NextLeaf Solutions Ltd.
Inventor： KO, Ryan Delmoral
IPC: B01D11/02 , A23L33/105 , A61K31/05 , A61K31/352 , A61K36/185 , C07C39/23 , C07D311/80
-
29.发明公开
公开(公告)号：EP3687527A1
公开(公告)日：2020-08-05
申请号：EP18857814.0
申请日：2018-09-25
Applicant: Canopy Health Innovations
Inventor： MACNAIR, Laura , BATAL, Rami , HETHERINGTON, Mark Andrew , WARE, Mark , SCHNARR, Chris , KRAWCYZK, Steve
IPC: A61K31/352 , A61K31/015 , A61K31/05 , A61K31/192 , A61K36/185 , A61P25/20 , C07C13/42 , C07C39/23 , C07C65/19 , C07D311/80
-
公开(公告)号：EP3319952B8
公开(公告)日：2020-03-11
申请号：EP16741447.3
申请日：2016-07-01
Applicant: Purisys LLC
Inventor： DIALER, Lukas , PETROVIC, Denis , WEIGL, Ulrich
IPC: C07D311/04 , C07D311/80
-
-
-
-
-
-
-
-
-
Search Results
382
records
(took 0.014 seconds)
